Insider Trading & Ownership of SRINIVAS AKKARAJU

Location
Palo Alto, CA
Summary
The estimated net worth of SRINIVAS AKKARAJU is at least $370M dollars as of 22 Dec 2025. SRINIVAS AKKARAJU is the Director, 10%+ Owner of Kalaris Therapeutics, Inc. and owns shares of Kalaris Therapeutics, Inc. (KLRS) stock worth about $95.3M. SRINIVAS AKKARAJU is the Director of Mineralys Therapeutics, Inc. and owns shares of Mineralys Therapeutics, Inc. (MLYS) stock worth about $91.4M. SRINIVAS AKKARAJU is the Director of vTv Therapeutics Inc. and owns shares of vTv Therapeutics Inc. (VTVT) stock worth about $76.4M. SRINIVAS AKKARAJU is the Director of Scholar Rock Holding Corp and owns shares of Scholar Rock Holding Corp (SRRK) stock worth about $69.4M. SRINIVAS AKKARAJU is the Director of ALUMIS INC. and owns shares of ALUMIS INC. (ALMS) stock worth about $37.3M. SRINIVAS AKKARAJU is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. (SYRS) stock worth about $20.1K.
Signature
Samsara Opportunity Fund, L.P., By Samsara Opportunity Fund GP, LLC, its General Partner, By /s/ Srinivas Akkaraju, Managing Member
All Insider Reports
All Insider Reports

Notify me when SRINIVAS AKKARAJU files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of SRINIVAS AKKARAJU

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KLRS Kalaris Therapeutics, Inc. Director, 10%+ Owner $95.3M 22 Dec 2025
MLYS Mineralys Therapeutics, Inc. Director $91.4M +$23.1M +33.8% 04 Sep 2025
VTVT vTv Therapeutics Inc. Director $76.4M 22 Sep 2025
SRRK Scholar Rock Holding Corp Director $69.4M +$20M +40.4% 07 Oct 2025
ALMS ALUMIS INC. Director $37.3M +$10.5M +39.4% 05 Dec 2025
SYRS Syros Pharmaceuticals, Inc. Director $20.1K 16 Sep 2024
KDNY CHINOOK THERAPEUTICS, INC. Director 11 Aug 2023
ICPT INTERCEPT PHARMACEUTICALS, INC. Director 08 Nov 2023
JYAC Jiya Acquisition Corp. Director, 10%+ Owner 23 Sep 2022

Insider Transactions Reported by SRINIVAS AKKARAJU:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.